Cerebrospinal fluid viral replication and burden of resistance in three HIV-1-infected people taking Ibalizumab with multiple drug class-wide resistance

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2152-2155
Number of pages4
JournalAIDS (London, England)
Volume34
Issue number14
DOIs
Publication statusPublished - Nov 15 2020

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Cite this